Nadim Yared - Jun 29, 2021 Form 3 Insider Report for CVRx, Inc. (CVRX)

Role
Chief Executive Officer, Director
Signature
/s/ Amy C. Seidel, Attorney-in-Fact
Stock symbol
CVRX
Transactions as of
Jun 29, 2021
Transactions value $
$0
Form type
3
Date filed
6/29/2021, 09:04 PM
Next filing
Nov 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVRX Common Stock 7.59K Jun 29, 2021 By trust for children

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVRX Stock Option Jun 29, 2021 Common Stock 31K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 3.79K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 5.92K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 12.6K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 11.4K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 15.7K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 5.06K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 10.1K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 10.1K $0.24 Direct F2
holding CVRX Stock Option Jun 29, 2021 Common Stock 37.1K $0.24 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 70K $0.24 Direct F3
holding CVRX Stock Option Jun 29, 2021 Common Stock 76.6K $0.24 Direct F4
holding CVRX Stock Option Jun 29, 2021 Common Stock 88.5K $3.96 Direct F5
holding CVRX Stock Option Jun 29, 2021 Common Stock 50.9K $4.35 Direct F1
holding CVRX Stock Option Jun 29, 2021 Common Stock 50.2K $4.35 Direct F6
holding CVRX Stock Option Jun 29, 2021 Common Stock 45.6K $4.35 Direct F7
holding CVRX Stock Option Jun 29, 2021 Common Stock 44.9K $4.35 Direct F8
holding CVRX Stock Option Jun 29, 2021 Common Stock 50.6K $7.12 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Fully exercisable, subject to Issuer's right to repurchase shares at exercise price, which repurchase right lapses with respect to 25% of the shares on the first anniversary of the date on which a certain revenue metric is achieved and with respect to the 1/48th of the shares on each month thereafter.
F3 Fully exercisable, subject to Issuer's right to repurchase shares at the exercise price, which repurchase right lapsed with respect to 25% of the shares on February 16, 2019 and lapses as to 1/48th of the shares each month thereafter.
F4 Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares on the 15th of each month thereafter.
F5 Vested as to 25% of the shares on July 24, 2020 and vests as to 1/48th of the shares on each month thereafter
F6 Vests as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
F7 Vests as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares on each month thereafter.
F8 Vests as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares on each month thereafter.
F9 Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares on each month thereafter.